Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00424138 · ClinicalTrials.gov registry record · NA
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
A NA study, sponsored by American College of Radiology Imaging Network.
- Terminated
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT00424138 is a NA study that was terminated before completion, run by American College of Radiology Imaging Network. The registered enrollment target is 96 participants.
The verdict
NCT00424138, a NA study, was terminated before completion, sponsored by American College of Radiology Imaging Network.
- TERMINATED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18 (\^18FDG) positron emission tomography (PET)/CT scans, may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying \^18FDG PET/CT scans to see how well they predict response in patients undergoing chemotherapy for stage IIIB or stage IV non-small cell lung cancer.
Interventions
- RADIATION FDG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2007-03-30 |
| Est. Completion | 2011-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00424138
The ClinicalTrials.gov registry entry for NCT00424138 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American College of Radiology Imaging Network, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDG is the first listed.
NCT00424138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00424138 about?
NCT00424138 is a clinical study titled "FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy". RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18 (\^18FDG) positron emission tomography (PET)/CT scans, may help doctors predict a patient's response to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying \^18FDG PET/CT scans to see how well they predi...
What is the current status of trial NCT00424138?
This trial is currently terminated. It is a NA study. The enrollment target is 96 participants. The study started on 2007-03-30. Estimated completion is 2011-08-31.
What interventions are being tested in trial NCT00424138?
The interventions under investigation include: FDG (RADIATION).
Who is sponsoring clinical trial NCT00424138?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.